UBS Maintains Neutral on Docusign, Raises Price Target to $70

Benzinga Newsdesk www.benzinga.com Positive 57.7%

Neg 0% Neu 0% Pos 57.7%

UBS analyst Karl Keirstead maintains Docusign (NASDAQ:DOCU) with a Neutral and raises the price target from $54 to $70.

Comments

No comments yet. Be the first!